MRNA

Moderna Inc (MRNA)

Healthcare • NASDAQ$145.13+8.86%

Key Fundamentals
Symbol
MRNA
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$145.13
Daily Change
+8.86%
Market Cap
$25.28B
Trailing P/E
N/A
Forward P/E
-12.93
52W High
$85.60
52W Low
$22.28
Analyst Target
$50.84
Dividend Yield
N/A
Beta
0.90
About Moderna Inc

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and c

Company website

Research MRNA on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...